Jim Simons Macrogenics Inc Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Macrogenics Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,326,494 shares of MGNX stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,326,494

Previous 1,152,270 15.12%

Holding current value

$2.26 Million

Previous $1.46 Million 9.71%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$1.06 - $1.79 $184,677 - $311,860	174,224 Added 15.12%	1,326,494 $1.61 Million
Q1 2025 May 14, 2025	BUY	$1.26 - $3.49 $773,321 - $2.14 Million	613,747 Added 113.97%	1,152,270 $1.46 Million
Q4 2024 Feb 13, 2025	BUY	$3.18 - $4.46 $699,918 - $981,646	220,100 Added 69.12%	538,523 $1.75 Million
Q3 2024 Nov 13, 2024	SELL	$3.0 - $5.55 $496,812 - $919,102	-165,604 Reduced 34.21%	318,423 $1.05 Million
Q2 2024 Aug 09, 2024	SELL	$3.31 - $18.51 $764,610 - $4.28 Million	-231,000 Reduced 32.31%	484,027 $2.06 Million
Q1 2024 May 13, 2024	SELL	$9.77 - $21.47 $473,845 - $1.04 Million	-48,500 Reduced 6.35%	715,027 $10.5 Million
Q4 2023 Feb 13, 2024	BUY	$4.48 - $10.11 $440,728 - $994,591	98,377 Added 14.79%	763,527 $7.35 Million
Q3 2023 Nov 14, 2023	SELL	$4.48 - $6.19 $401,735 - $555,075	-89,673 Reduced 11.88%	665,150 $3.1 Million
Q2 2023 Aug 11, 2023	BUY	$4.62 - $7.54 $831,600 - $1.36 Million	180,000 Added 31.31%	754,823 $4.04 Million
Q1 2023 May 12, 2023	BUY	$4.82 - $7.24 $441,994 - $663,908	91,700 Added 18.98%	574,823 $4.12 Million
Q4 2022 Feb 13, 2023	SELL	$3.34 - $6.98 $87,174 - $182,178	-26,100 Reduced 5.13%	483,123 $3.24 Million
Q3 2022 Nov 14, 2022	SELL	$3.01 - $5.22 $2.77 Million - $4.81 Million	-921,700 Reduced 64.41%	509,223 $1.76 Million
Q2 2022 Aug 12, 2022	BUY	$2.25 - $9.99 $1.9 Million - $8.44 Million	845,211 Added 144.3%	1,430,923 $4.22 Million
Q1 2022 May 13, 2022	BUY	$8.12 - $16.9 $4.76 Million - $9.9 Million	585,712 New	585,712 $5.16 Million
Q2 2020 Aug 13, 2020	SELL	$5.2 - $29.12 $2.43 Million - $13.6 Million	-468,123 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$4.28 - $12.11 $68,480 - $193,760	16,000 Added 3.54%	468,123 $2.72 Million
Q4 2019 Feb 13, 2020	BUY	$7.95 - $12.27 $141,271 - $218,037	17,770 Added 4.09%	452,123 $4.92 Million
Q3 2019 Nov 13, 2019	BUY	$12.44 - $17.48 $123,529 - $173,576	9,930 Added 2.34%	434,353 $5.54 Million
Q2 2019 Aug 12, 2019	SELL	$14.51 - $19.71 $5.79 Million - $7.87 Million	-399,300 Reduced 48.48%	424,423 $7.2 Million
Q1 2019 May 14, 2019	BUY	$11.11 - $25.6 $6.97 Million - $16.1 Million	627,623 Added 320.05%	823,723 $14.8 Million
Q4 2018 Feb 13, 2019	BUY	$11.75 - $21.42 $2.3 Million - $4.2 Million	196,100 New	196,100 $2.49 Million

Others Institutions Holding MGNX

# of Institutions

119

Shares Held

52.3M

Call Options Held

55.3K

Put Options Held

35.9K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $104M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account